Clarivate Plc

Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clarivate Plc reports strong Q4 earnings, eyes growth opportunities

Clarivate Plc delivered strong financial results in Q4 2022, driven by the successful ProQuest acquisition and solid organic growth across segments. The company is focused on achieving higher organic growth, reducing leverage, and leveraging culture for success.
While facing macroeconomic challenges and pricing pressures, Clarivate Plc is confident in its strategic plans and capital structure initiatives. Opportunities lie in leveraging AI, enhancing product offerings, and capitalizing on the positive pricing environment.
Navigating challenges such as tough comps, managing inflation impact, and balancing quarterly patterns will be crucial. The company's proactive approach to growth, focus on customer value, and upcoming Investor Day position it well for future success.

Clarivate Plc reports stable Q1 performance amidst growth challenges

Clarivate Plc's Q1 2023 performance showcased stable revenue, strong margins, and strategic financial initiatives despite challenges in net income and organic growth cadence.
The company's strengths lie in market engagement, AI innovation, maintained outlook, and effective pricing strategies, positioning it for continued growth.
Challenges include earnings volatility, execution hurdles in growth projections, and longer-term segment revenue impacts, necessitating strategic planning and operational focus.
Opportunities in AI applications, cash flow utilization, revenue drivers, and segment progress offer avenues for revenue diversification, growth investments, and market expansion.

Clarivate Plc faces revenue challenges but drives growth through innovation

Clarivate Plc's Q2 performance saw challenges in key segments impacting revenue and outlook, despite operational improvements and strategic initiatives.
While facing hurdles in patent annuities and commercialization subsegment growth, the company focuses on sustainability, product innovations, and customer-centric strategies for future growth.
Detailed financial results and revised guidance reflect the company's proactive approach to address challenges and capitalize on opportunities for sustainable growth.
With a pivot around three segments and emphasis on higher-touch sales, Clarivate aims to navigate challenges, leverage opportunities, and drive revenue growth in the evolving market landscape.

Clarivate Plc reports Q3 growth, tackles challenges, eyes tech acquisitions

Clarivate Plc's Q3 performance showed growth in key segments despite challenges in IP and LS&H businesses.
Opportunities lie in technology acquisitions, analytic platforms, and direct sales to pharma companies.
Management remains optimistic about quarterly results and progress, focusing on enhancing growth strategies.

Clarivate Plc reports solid Q4 performance amidst sector challenges

Clarivate Plc's Q4 2023 performance reflects progress in key segments and a strategic focus on organic growth and operational efficiencies.
While facing challenges in the A&G segment and market conservatism, the company is leveraging strengths in Life Sciences investments and pricing strategies.
Opportunities lie in growth acceleration through new offerings, improved organic growth, and renewed optimism in the life sciences sector.

Clarivate Plc reports Q1 revenue growth, eyes segment expansion

Clarivate Plc's Q1 performance showed promising organic revenue growth and steady renewal rates, with a focus on future investments for growth.
While facing financial challenges and neutral market conditions, the company sees opportunities in segment growth and real-world data solutions.
Overall, Clarivate remains on track with full-year guidance, aiming for 1% organic growth and focusing on driving subscription business growth.

Clarivate Plc reports mixed Q2 results, focuses on growth strategies

Clarivate Plc reported mixed financial results in Q2 2024, with slight revenue growth but challenges in certain segments.
Management emphasized resilience in adjusted EPS and operating cash flow, focusing on growth plans and operational improvements.
Analysts raised concerns about project delays and segment performance, but opportunities in product innovation and revenue growth were highlighted.
The company aims to drive subscription revenue growth through upcoming product releases and investment in business.

Clarivate Plc faces revenue decline in Q3 but focuses on growth strategies

Clarivate Plc's Q3 2024 earnings call highlighted challenges in revenue decline and net loss, with a focus on repositioning and value creation. The company is implementing a Value Creation Plan to optimize its business model and drive sustainable growth. Opportunities exist in improving sales execution, product innovation, and aligning the portfolio for enhanced profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Clarivate PLC (CLVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clarivate PLC (CLVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Strengthens Newfold Digital's enterprise domain management capabilities JACKSONVILLE, Fla. , Nov. 1, 2022 /PRNewswire/ -- Newfold Digital ("Newfold"), a leading web and commerce technology provider backed by affiliates of Clearlake Capital Group, L.P.

Newfold Digital Completes Acquisition of MarkMonitor from Clarivate

LONDON , Nov. 1, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation today announced that it has successfully completed the divestiture of MarkMonitor™, an industry-leading enterprise-level provider of domain management solutions, to Newfold Digital ("Newfold"), a leading web and commerce technology provider backed by affiliates of Clearlake Capital Group, L.P. ("Clearlake") and Siris Capital Group, LLC ("Siris").

Clarivate Successfully Completes Divestiture of MarkMonitor to Newfold Digital

Oceanic power at the cusp of innovation while energies including solar photovoltaic and wind power approaches technical maturity LONDON , Oct. 26, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report, A study of energy in transition: the role of research and innovation in the world's shift to sustainable energy sources . It finds that innovation activity in the sustainable energy space is tailing off, as research and inventive activities for respective renewable develops at different paces.

Clarivate Identifies the Role of Research and Innovation in the World's Shift to Sustainable Energy

Report analyzes benefits, financing, R&D activity and more to reveal emerging standouts in medical science United States and Mainland China at the forefront of RNA technology advancement LONDON, Oct. 25, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report, RNA Technology Companies to Watch. The report identifies seven emerging innovators in the field of medical science who are solving for undruggable disease targets.

Clarivate Identifies Seven Innovators in New RNA Technology Companies to Watch Report

LONDON , Oct. 20, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released an in-depth look at formal regional research assessment, co-authored by the Institute for Scientific Information at Clarivate, together with esteemed industry partners: Kate Williams, University of Melbourne; Jonathan Grant, Different Angles; Lutz Bornmann, Max Planck Institute and Martin Szomszor, Electric Data Solutions. Research assessment: origins, evolution, outcomes  examines the origins of research assessment, and how it works in different regions via the approaches of Australia, Canada, Germany, Hong Kong, New Zealand and the United Kingdom.

Clarivate Global Research Report Examines Role of Research Assessment with a Review of Six Regional Systems

71 'Citation Laureates' named by the Institute for Scientific Information, some as early as a decade ago, have now received a Nobel Prize LONDON , Oct. 12, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates the seven new Nobel Laureates across the fields of science and economics who were accurately identified as potential Nobel Prize recipients. Each individual was awarded the designation of Citation Laureate™ several years before being named by the Nobel Assembly – four, more than a decade – thanks to expert interpretation of high-quality citation data at Clarivate.

Clarivate Experts Celebrate 2022 Nobel Success with Seven Laureates Identified via Citation Analysis

Announces plans for Investor Day in 2023 LONDON , Sept. 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the third quarter 2022 before the market opens on Tuesday, November 8.

Clarivate to Report Third Quarter 2022 Results on November 8, 2022

Recognizing peer review via the  next generation of Web of Science Researcher Profiles LONDON , Sept. 22, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates Peer Review Week with the announcement of new services for authors to better track their peer review activity.

Clarivate Supports Peer Review Week by Raising the Profile of Peer Reviewers

64 Citation Laureates named by the Institute for Scientific Information have gone on to receive a Nobel Prize LONDON , Sept. 21, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today named 20 world-class researchers from four countries as Citation Laureates™.

Clarivate Reveals Citation Laureates 2022 - Annual List of Researchers of Nobel Class

Migration of BioWorld Science to complete BioWorld brand consolidation LONDON , Sept. 15, 2022 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced BioWorld Science will transition entirely to bioworld.com for an improved experience and expanded news offering.

BioWorld by Clarivate Adds Laser-focused Preclinical Research News into New Fully Integrated Platform

Clarivate focusing on enabling corporations and law firms to innovate faster and unlock the true value of IP across patents, trademarks and copyright MarkMonitor to strengthen Newfold Digital's enterprise domain management capabilities LONDON and JACKSONVILLE, Fla. , Sept. 12, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that Newfold Digital ("Newfold"), a leading web and commerce technology provider backed by Clearlake Capital Group, L.P.

Newfold Digital Signs Agreement to Acquire MarkMonitor from Clarivate

The late Dr . Saeed Ul Hassan 's proposal for innovation in science communications using AI wins the 2022 award LONDON , Sept.

Clarivate Announces Winner of the 2022 Eugene Garfield Award for Innovation in Citation Analysis

LONDON , Sept. 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jonathan Gear, Chief Executive Officer, and Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the following investor conferences in September 2022.

Clarivate to Present at Upcoming Investor Conferences in September 2022

Andy Snyder to Become Chair of the Board in October Board appoints Jerre Stead to the role of Chairman Emeritus LONDON , Sept. 1, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jonathan Gear has assumed the role of Chief Executive Officer with the retirement of Jerre Stead from that role.

Jonathan Gear Assumes Chief Executive Officer Role for Clarivate with Jerre Stead Retirement

Clarivate Plc (NYSE:CLVT ) Q2 2022 Earnings Conference Call August 9, 2022 9:00 AM ET Company Participants Mark Donohue - Head of IR Jerre Stead - Executive Chair & CEO Jonathan Gear - CEO Jonathan Collins - CFO Gordon Samson - Chief Product Officer Steen Lomholt-Thomsen - Chief Revenue Officer Conference Call Participants Manav Patnaik - Barclays George Tong - Goldman Sachs Hans Hoffman - Jefferies Ashish Sabadra - RBC Capital Markets Trevor Romeo - William Blair Toni Kaplan - Morgan Stanley Operator Good morning. Thank you for attending today's Clarivate Second Quarter 2022 Earnings Conference.

Clarivate Plc (CLVT) CEO Jerre Stead on Q2 2022 Results - Earnings Call Transcript

Investors weren't happy to see management's new 2022 outlook.

Why Clarivate Stock Dove Today

— Updates 2022 Outlook — LONDON , Aug. 9, 2022 /PRNewswire/ -- Clarivate Plc - (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today reported results for the second quarter ended June 30, 2022. Second Quarter 2022 Financial Highlights Revenues of $686.6 million increased 54.0%, and 59.9% at constant currency Organic revenues(1) increased 4.8% Net income attributable to ordinary shares of $43.7 million increased $175.2 million; Net loss per diluted share of $0.00 improved by $0.22 Adjusted Net Income(1) of $165.1 million increased 50.1%; Adjusted Income per diluted share(1) of $0.22 increased 29.4% or $0.05 Adjusted EBITDA(1) of $274.4 million increased 45.2% and Adjusted EBITDA Margin(1) of 39.9% decreased 240 basis points First Half of 2022 Financial Highlights Revenues of $1,348.8 million increased 54.3%, and 58.8% at constant currency Organic revenues(1) increased 4.6% Net income attributable to ordinary shares of $94.5 million increased $282.0 million; Net loss per diluted share of $0.07 improved by $0.28 Adjusted Net Income(1) of $320.2 million increased 61.4%; Adjusted Income per diluted share(1) of $0.43 increased 38.7% or $0.12 Adjusted EBITDA(1) of $536.7 million increased 51.7% and Adjusted EBITDA Margin(1) of 39.8% decreased 50 basis points Cash Flow from Operations decreased $97.1 million to $164.6 million; Adjusted Free Cash Flow(1) decreased $0.4 million to $258.1 million "We delivered a good quarter with organic revenue growth approaching 5% as our One Clarivate strategy is building traction across our global customer base," said Jerre Stead, Executive Chair and CEO.

Clarivate Reports Second Quarter 2022 Results

Providing software solutions from Innovative for library staff and patrons across the country LONDON , Aug. 8, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has been selected by The National Library Board of Singapore (NLB) to provide library software solutions from Innovative, part of Clarivate, to support NLB's Libraries and Archives Blueprint 2025 (LAB25). Under the contract, the Polaris Integrated Library System (ILS) and Vega Discover applications from Innovative will be used by NLB as automation solutions for its library staff and patrons across Singapore.

Clarivate Selected by Singapore's National Library Board to Play a Part in Building Libraries of the Future

Research must rise to meet challenges such as microplastics pollution and climate change LONDON , July 27, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launched a new Global Research Report from the Institute for Scientific Information™ analyzing ocean science research over the last two decades. The report concludes that research must rise to meet the challenges facing the marine environment such as microplastic pollution and climate change.

Clarivate Launches New Global Research Report Urging Action on Ocean Science

LONDON , July 26, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that in the 2023 release of the Journal Citation Reports all Web of Science Core Collection™ journals will receive a Journal Impact Factor (JIF)™. This means expanding the JIF from Science Citation Index Expanded (SCIE)™ and Social Science Citation Index (SSCI)™ to include journals from the Arts and Humanities Citation Index (AHCI)™ and the multidisciplinary Emerging Sources Citation Index (ESCI)™.

Clarivate announces changes to the 2023 Journal Citation Reports All Web of Science Core Collection journals, including arts and humanities will have Journal Impact Factors

MarkMonitor becomes the first and only foreign-owned domain name registrar licensed in Mainland China to offer .com, .cn and .net  Top Level Domains LONDON , July 21, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced it is the first and only licensed foreign-owned domain name registrar in Mainland China to offer a wide range of Top Level Domains including .com, .net, .cn, .中国, to companies hosting website content locally.

Clarivate Awarded Expanded License for Domain Service in Mainland China

Special report on aging investigates the latest science, key biological drivers and companies driving the development of potential "Fountain of Youth" candidate drugs LONDON , July 20, 2022 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report, Extending the Human Lifespan, which examines the science around extending our time on earth alongside our quality of life. The report provides an in-depth analysis of the latest science, the key biological drivers that can be targeted pharmacologically and the companies developing these potential "Fountain of Youth" candidate drugs.

BioWorld by Clarivate Explores the Concept of Extending Human Lifespan in New Report

LONDON , July 11, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that Jerre Stead, Executive Chair and Chief Executive Officer, is retiring from his CEO role effective September 1, 2022, but will continue as Non-Executive Chair of the Board of Directors. During Mr.

Clarivate Announces Retirement of Chief Executive Officer Jerre Stead and Appointment of Jonathan Gear as New CEO

LONDON , July 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the second quarter 2022 before the market opens on Tuesday, August 9. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at https://ir.clarivate.com.

News for Clarivate Plc Stock (CLVT)